Five IPOs are scheduled for the week ending October 16, 2020. 25-day underwriter research quiet periods end for 15 companies. There are no scheduled 180-day shareholder sale lockup period expirations.
Monday, October 12
Outset Medical, (OM), Medical Devices
Snowflake, (SNOW), Enterprise IT
StepStone, (STEP), Financial Services
Metacrine, (MTCR), Biopharma
JFrog, (FROG), Enterprise IT
Dyne Therapeutics, (DYN), Biopharma
Broadstone Net Lease, (BNL), REIT
Sumo Logic, (SUMO), Enterprise IT
American Well Corporation, (AMWL), Healthcare IT
Pactiv Evergreen, (PTVE), Consumer
Unity Software, (U), Digital Media
Athira Pharma, (ATHA), Biopharma
Vitru, (VTRU), EdTech
BioVie, (BIVI), Biopharma
COMPASS Pathways, (CMPS), Biopharma
Tuesday, October 13
Codiak BioSciences, (CDAK), Biopharma, $14.00 – $16.00, IPOs On TheStreet Opinion: BUY – Read It
Wednesday, October 14
Array Technologies, (ARRY), Alternative Energy, $19.00 – $21.00, IPOs On TheStreet Opinion: BUY – Read It
MINISO Group, (MNSO), Retail, $16.50 – $18.50, IPOs On TheStreet Opinion: NEUTRAL – Read It
Spinal Elements, (SPEL), Medical Devices, $13.00 – $15.00, IPOs On TheStreet Opinion: NEUTRAL – Read It
Thursday, October 15
Friday, October 16
Day to Day
Praxis Precision Medicines, (PRAX), Biopharma, $16.00 – $18.00, IPOs On TheStreet Opinion: BUY – Read It
Initial Public Offering pricing date. The calendar date referenced for each IPO is the expected pricing date. The trading date is usually the following day.
End of the customary 25-day period after an IPO during which the major analyst firms who have been involved in the IPO do not publish research on the company.
End of the customary 180-day period after an IPO during which pre-IPO shareholders may not sell their shares.
Glossary Of Terms
(I have no position in any stocks mentioned as of the article date, no plans to initiate any positions within